A London hospital trust has entered a partnership with an artificial intelligence (AI) company to develop new digital solutions for healthcare, with the first step being the launch of a mobile clinical application for detecting acute kidney injury (AKI). The Royal Free London NHS Foundation Trust has announced a five-year deal with DeepMind, which became established as one of the leaders in the field when it was acquired by Google in 2014. It follows on from a year-long partnership between the two organisations, in which they have developed the Streams app, which processes new and historic patient data to support clinicians in making diagnoses. It has now been registered with the Medicines and Healthcare products Regulatory Agency (MHRA) and will be deployed to the foundation's clinicians from early next year. David Sloman, chief executive of the Royal Free London, said: "We are hugely excited by the opportunity this partnership presents to patients and staff.